FDPS
MOLECULAR TARGETfarnesyl diphosphate synthase
FDPS (farnesyl diphosphate synthase) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting FDPS
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | risedronic acid | 4.09 | 59 |
| 2 | ibandronic acid | 3.22 | 24 |
| 3 | minodronic acid | 2.30 | 9 |
| 4 | hexylaminomethylenediphosphonic acid | 1.79 | 5 |
| 5 | Isopentenyladenosine N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is | 1.61 | 4 |
| 6 | Zoledronic Acid | 1.39 | 3 |
About FDPS as a Drug Target
FDPS (farnesyl diphosphate synthase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented FDPS interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
FDPS inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.